Manage the Cost of Specialty Pharmaceuticals, Biotech Therapies and Injectables
Featured Conference Manage the Cost of Specialty Pharmaceuticals, Biotech Therapies and Injectables January 24...
Pharma Profits on Slippery Slope?
Some fourth quarter data are in from the pharmaceutical industry and, on the surface, it looks good for profits:
Pfizer said it earned $4.39 billion,...
Drug Prices/Declining Profits Top Issues for 2005
According to results of the recent Pharma Marketing News 2005 HOT ISSUE survey, drug prices, declining profits, and dwindling pipeline of new drugs are...
How the FDA Can Fix DTC
According to today's Financial Times (FT), executives from UK pharma companies GlaxoSmithKline and AstraZeneca told a UK parliamentary committee they did not believe it...
Does the FDA Need to be Overhauled?
The Vioxx withdrawal put the Food and Drug Administration (FDA) under the spotlight. There were allegations that the FDA was in cahoots with Merck...
Drug Prices, Declining Profits Top Pharma Concern
The Pharma Marketing News 2005 HOT ISSUE Survey reveals some insight into the issues of most concern to pharmaceutical marketers in 2005. At the...
ED Drug Sales Limp
The Wall Street Journal reports today that all is not well in the impotence-drug market.
"The growth since the competition came to the market has...
The End of DTC as We Know It
During the presidential election campaign of 2004, several pharma industry trade publications suggested that if Kerry/Edwards won the election, DTC (Direct to Consumer) ads...
Canada: Mad Cows Yes, Drugs No!
Canadian health officials are drafting a proposal that could halt Internet sales of prescription drugs to U.S. consumers, which could "essentially kill" a $700...
The Pharma Industry Has Issues in 2005
In his excellent article, What Merck has to do to remain an independent drug maker, business writer Donald Johnson lists the following 10 scientific,...
